# US 2012/0253771 A1 · Syetem for Optimizing Treatment Strategies Using a Patient-Specific Rating System

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0253771 A1
- Document ID: US20120253771A1
- Status: Published application
- Kind: A1
- Application number: 13/517,576
- Filed: 2012-06-13
- Published: 2012-10-04
- Earliest claimed: 2004-08-26
- Inventors: Nananda F. Col; Griffin Weber
- Web page: https://patentgrep.com/patent/US20120253771A1

## CPC

- G16H 50/20: for computer-aided diagnosis, e.g. based on medical expert systems
- G16H 50/30: for calculating health indices; for individual health risk assessment
- G16H 50/50: for simulation or modelling of medical disorders
- G16Z 99/00: Subject matter not provided for in other main groups of this subclass
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16Z: INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR

## Abstract

The combined effects of a selected treatment option on multiple causes of morbidity or mortality are simulated for evaluation. Various patient-specific and model-specific parameters, including parameters related to diseases to be modeled, are used in modeling incidence and mortality rates for each disease. These disease-specific models are used for defining a set of health states having initial probabilities, which are used to formulate a transition matrix used in matrix calculation to obtain output matrix Q. If additional cycles are needed, the transition matrix is updated and matrix calculation is performed using the updated transition matrix. Otherwise, final output matrix Q is utilized for calculation of values needed for determining an overall treatment score. The calculated values and/or values from Q are combined with patient or numeric scores from other treatment choice-related domains to obtain a raw score that is used to produce a patient-specific score for a selected treatment option.

## Claims

### Claim 1

A computer-based method for evaluating the effect of a selected treatment option on a specific patient, comprising the steps of:
creating, utilizing a computer-based risk prediction modeling component, at least one disease risk prediction model for the specific patient;
defining a set of health states for the patient, each health state having an initial probability value, wherein each possible combination of diseases is assigned a unique health state;
formulating a mathematical transition matrix based on the disease risk prediction model and the set of health states;
performing, using the transition matrix and a computer-based matrix processing component, mathematical matrix calculation to obtain a mathematical an output matrix and directly update the probability values of the health states;
if additional cycles are needed, performing the steps of:
updating the transition matrix; and
using the updated transition matrix and the computer-based matrix processing component, performing mathematical matrix calculation to update the output matrix; and
utilizing the output matrix, deriving at least one derived value related to the combined effect of the treatment option on multiple causes of morbidity or mortality.

### Claim 2 (depends on 1)

The method of claim 1, further comprising the steps of:
combining, to obtain a raw score, at least two values selected from the group consisting of derived values related to the effect of the treatment option, values from the output matrix, and numeric scores from other treatment choice-related domains; and
utilizing the raw score, obtaining a patient-specific score for the selected treatment option.

### Claim 3 (depends on 2)

The method of claim 2, further comprising the step of comparing the patient-specific score for the selected treatment option to at least one patient-specific score for another treatment option.

### Claim 4 (depends on 1)

The method of claim 1, further comprising the step of obtaining at least one model-specific, disease-specific, treatment-specific, or user-specific parameter from a user.

### Claim 5 (depends on 1)

The method of claim 1, further comprising the step of providing at least one derived value related to the effect of the treatment option to a user through an interactive user interface.

### Claim 6 (depends on 1)

The method of claim 1, wherein the derived value is selected from the group consisting of life expectancy (LE), quality-adjusted life expectancy (QALE), cumulative disease-specific incidence or mortality, LE with a discount rate, and QALE with a discount rate.

### Claim 7 (depends on 2)

The method of claim 2, wherein the step of combining utilizes at least one numeric score from other treatment choice-related domains that is selected from the group consisting of major treatment side-effects, minor treatment side-effects, convenience of dosing, route of dosing, costs, ethical concerns, health beliefs, religious beliefs, and long-term consequences of treatment.

### Claim 8 (depends on 2)

The method of claim 2, the step of combining comprising the steps of:
assigning weights to each domain;
weighting each value according to its domain; and
combining the weighted values from each domain.

### Claim 9 (depends on 8)

The method of claim 8, the step of assigning weights to each domain comprising the step of pair-wise comparing increments of gains or losses in one domain to incremental gains or losses in each other domain using a common preference scale.

### Claim 10

A computer-based method for evaluating the effect of a selected treatment option on a specific patient, comprising the steps of:
combining, in a computer-based score calculation processor to obtain a raw score, at least two values selected from the group consisting of treatment option-related values derived through modeling techniques, calculated values derived from the treatment option-related values, and numeric scores from other treatment choice-related domains; and
utilizing the raw score, obtaining a patient-specific score for the selected treatment option.

### Claim 11 (depends on 10)

The method of claim 10, further comprising the step of comparing the patient-specific score for the selected treatment option to at least one patient-specific score for another treatment option.

### Claim 12 (depends on 10)

The method of claim 10, wherein at least one treatment option-related value derived through modeling techniques is obtained through the steps of:
creating at least one disease risk prediction model for the specific patient;
defining a set of health states for the patient, each health state having an initial probability value, wherein each possible combination of diseases is assigned a unique health state;
formulating a mathematical transition matrix based on the disease risk prediction model and the set of health states;
using the transition matrix, performing mathematical matrix calculation to obtain a mathematical output matrix comprising at least one treatment option-related value and directly update the probability values of the health states;
if additional cycles are needed, performing the steps of:
updating the transition matrix; and
using the updated transition matrix, performing mathematical matrix calculation to update the output matrix; and
utilizing the output matrix, deriving at least one derived value related to the combined effect of the treatment option on multiple causes of morbidity or mortality.

### Claim 13 (depends on 12)

The method of claim 12, further comprising the step of utilizing the output matrix in deriving at least one calculated value derived from the treatment option-related values.

### Claim 14 (depends on 10)

The method of claim 10, further comprising the step of providing at least one patient-specific score to a user through an interactive user interface.

### Claim 15 (depends on 10)

The method of claim 10, wherein the step of combining utilizes at least one numeric score from other treatment choice-related domains that is selected from the group consisting of major treatment side-effects, minor treatment side-effects, convenience of dosing, route of dosing, costs, ethical concerns, health beliefs, religious beliefs, and long-term consequences of treatment.

### Claim 16 (depends on 10)

The method of claim 10, the step of combining comprising the steps of:
assigning weights to each domain;
weighting each value according to its domain; and
combining the weighted values from each domain.

### Claim 17 (depends on 16)

The method of claim 16, the step of assigning weights to each domain comprising the step of pair-wise comparing increments of gains or losses in one domain to incremental gains or losses in each other domain using a common preference scale.

### Claim 18

A non-transitory computer-readable medium, the computer-readable medium being characterized in that:
the computer-readable medium contains code that, when executed in a processor, implements a method for evaluating the effect of a selected treatment option on a specific patient by performing the steps of:
creating at least one disease risk prediction model for the specific patient;
defining a set of health states for the patient, each health state having an initial probability value, wherein each possible combination of diseases is assigned a unique health state;
formulating a mathematical transition matrix based on the disease risk prediction model and the set of health states;
performing, using the transition matrix, mathematical matrix calculation to obtain a mathematical output matrix and directly update the probability values of the health states;
if additional cycles are needed, performing the steps of:
updating the transition matrix; and
using the updated transition matrix, performing mathematical matrix calculation to update the output matrix; and
utilizing the output matrix, deriving at least one derived value related to the combined effect of the treatment option on multiple causes of morbidity or mortality.

### Claim 19 (depends on 18)

The computer-readable medium of claim 18, the medium being characterized in that:
the computer-readable medium further containing code that, when executed in a processor, performs the steps of:
combining, to obtain a raw score, at least two values selected from the group consisting of derived values related to the effect of the treatment option, values from the output matrix, and numeric scores from other treatment choice-related domains; and
utilizing the raw score, obtaining a patient-specific score for the selected treatment option.

### Claim 20 (depends on 19)

The computer-readable medium of claim 19, the medium being characterized in that:
the computer-readable medium further containing code that, when executed in a processor, performs the step of comparing the patient-specific score for the selected treatment option to at least one patient-specific score for another treatment option.

### Claim 21 (depends on 18)

The computer-readable medium of claim 18, the medium being characterized in that:
the computer-readable medium further containing code that, when executed in a processor, performs the step of obtaining at least one model-specific, disease-specific, treatment-specific, or user-specific parameter from a user.

### Claim 22 (depends on 18)

The computer-readable medium of claim 18, the medium being characterized in that:
the computer-readable medium further containing code that, when executed in a processor, performs the step of providing at least one derived value related to the effect of the treatment option to a user through an interactive user interface.

### Claim 23 (depends on 18)

The computer-readable medium of claim 18, wherein the derived value is selected from the group consisting of life expectancy (LE), quality-adjusted life expectancy (QALE), cumulative disease-specific incidence or mortality, LE with a discount rate, and QALE with a discount rate.

### Claim 24 (depends on 19)

The computer-readable medium of claim 19, wherein the step of combining utilizes at least one preference value from treatment choice-related domains selected from the group consisting of major treatment side-effects, minor treatment side-effects, convenience of dosing, route of dosing, costs, ethical concerns, health beliefs, religious beliefs, and long-term consequences of treatment.

### Claim 25 (depends on 19)

The computer-readable medium of claim 19, the medium being characterized in that:
the computer-readable medium further containing code that, when executed in a processor, performs the step of combining by the steps of:
assigning weights to each domain;
weighting each value according to its domain; and
combining the weighted values from each domain.

### Claim 26 (depends on 25)

The computer-readable medium of claim 25, the medium being characterized in that:
the computer-readable medium further containing code that, when executed in a processor, performs the step of assigning weights by the step of pair-wise comparing increments of gains or losses in one domain to incremental gains or losses in each other domain using a common preference scale.

### Claim 27

A non-transitory computer-readable medium, the computer-readable medium being characterized in that:
the computer-readable medium contains code that, when executed in a processor, implements a method for evaluating the effect of a selected treatment option on a specific patient by performing the steps of:
combining, to obtain a raw score, at least two values selected from the group consisting of treatment option-related values derived through modeling techniques, calculated values derived from the treatment option-related values, and numeric scores from other treatment choice-related domains; and
utilizing the raw score, obtaining a patient-specific score for the selected treatment option.

### Claim 28 (depends on 27)

The computer-readable medium of claim 27, the medium being characterized in that:
the computer-readable medium further containing code that, when executed in a processor, performs the step of comparing the patient-specific score for the selected treatment option to at least one patient-specific score for another treatment option.

### Claim 29 (depends on 27)

The computer-readable medium of claim 27, the medium being characterized in that:
the computer-readable medium further containing code that, when executed in a processor, performs the step of obtaining at least one treatment option-related value derived through modeling techniques by the steps of:
creating at least one disease risk prediction model for the specific patient;
defining a set of health states for the patient, each health state having an initial probability value, wherein each possible combination of diseases is assigned a unique health state;
formulating a mathematical transition matrix based on the disease risk prediction model and the set of health states;
using the transition matrix, performing mathematical matrix calculation to obtain a mathematical output matrix comprising at least one treatment option-related value and directly update the probability values of the health states;
if additional cycles are needed, performing the steps of:
updating the transition matrix; and
using the updated transition matrix, performing mathematical matrix calculation to update the output matrix; and
utilizing the output matrix, deriving at least one derived value related to the combined effect of the treatment option on multiple causes of morbidity or mortality.

### Claim 30 (depends on 29)

The computer-readable medium of claim 29, the medium being characterized in that:
the computer-readable medium further containing code that, when executed in a processor, performs the step of utilizing the output matrix in deriving at least one calculated value derived from the treatment option-related values.

### Claim 31 (depends on 27)

The computer-readable medium of claim 27, the medium being characterized in that:
the computer-readable medium further containing code that, when executed in a processor, performs the step of providing at least one patient-specific score to a user through an interactive user interface.

### Claim 32 (depends on 27)

The computer-readable medium of claim 27, wherein the step of combining utilizes at least one preference value from treatment choice-related domains selected from the group consisting of major treatment side-effects, minor treatment side-effects, convenience of dosing, route of dosing, costs, ethical concerns, health beliefs, religious beliefs, and long-term consequences of treatment.

### Claim 33 (depends on 27)

The computer-readable medium of claim 27, the medium being characterized in that:
the computer-readable medium further containing code that, when executed in a processor, performs the step of combining by the steps of:
assigning weights to each domain;
weighting each value according to its domain; and
combining the weighted values from each domain.

### Claim 34 (depends on 33)

The computer-readable medium of claim 33, the medium being characterized in that:
the computer-readable medium further containing code that, when executed in a processor, performs the step of assigning weights by the step of pair-wise comparing increments of gains or losses in one domain to incremental gains or losses in each other domain using a common preference scale.
